Enadoline

This classification denotes an opioid receptor agonist with the molecular formula C24H32N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KJL283326C, chemically known as 4-benzofuranacetamide, n-methyl-n-(7-(1-pyrrolidinyl)-1-oxaspiro(4.5)dec-8-yl)-, (5r-(5alpha,7alpha,8beta))- but generally known as enadoline, which bears US NIH Compound Identifier 60768. European Medicines Agency schedules Enadoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06513MIG. The term ENADOLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 7, No3, 1993, List 33). ENADOLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule enadoline under HS 29349990 and SITC 51579. As of Q4 2014, ENADOLINE remains the US FDA Preferred Term for this commodity. Enadoline bears US NLM identifiers UMLS ID C0209582 and NCI Concept Code C80576. SMILES: O1C2(CC(N3CCCC3)C(N(C)C(=O)CC3C4C(OCC4)CCC3)CC2)CCC1.